New Frontier Bio, Inc.
Molecular combinations inspired by nature designed to reverse aging and promote longevity at the cellular level
- Sector
- Biotech
- Headquarters
- BEVERLY, MA
- Founded
- 2020
- Latest Form D
- $309K, Jun 2024
- Total capital
- $9.2M
- Federal grants
- None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
- Private capital raised
- $9.2M
- 2 Form D · last Jun 2024
- 28 months since last filing
- Federal contracts
- None on recordNo federal contract awards found.
- Granted patents
- 0
- 5 pending
Capital timeline
Latest events
- Private capital raisedForm D · SEC · 2nd filing$309K
- Private capital raisedForm D · SEC · 1st filing$8.9M
Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.
Founders and team
From SEC Form D filings- James LintonDirectorNamed in SEC Form D filings
- Kaiyuan P. WangDirectorNamed in SEC Form D filings
- Kevin P. KongExecutive OfficerNamed in SEC Form D filings
- Serge P. SchoenDirectorNamed in SEC Form D filings
- Stephen Kennedy SmithExecutive Officer, Director, PromoterNamed in SEC Form D filings
- Vincent P. MaiDirectorNamed in SEC Form D filings
What it has protected
USPTO · 0 granted of 5- PendingNicotinate Esters And Therapeutic Methods Of Use ThereofUSPTOApplication 19170296
- PendingNicotinate And Nicotinamide Riboside-based Compounds And Derivatives ThereofUSPTOApplication 18104051
- PendingNicotinate Esters And Therapeutic Methods Of Use ThereofUSPTOApplication PCTUS2025023117
Show all 5 patent records
- Nicotinate Esters And Therapeutic Methods Of Use ThereofOct 9, 2025 · Application 19170296Pending
- Nicotinate And Nicotinamide Riboside-based Compounds And Derivatives ThereofAug 3, 2023 · Application 18104051Pending
- Nicotinate Esters And Therapeutic Methods Of Use ThereofApplication PCTUS2025023117Pending
- Nicotinate And Nicotinamide Riboside-based Compounds And Derivatives ThereofApplication PCTUS2023011957Pending
- Methods Of Making Nicotinate/nicotinamide Riboside-based Compounds And Derivatives ThereofApplication 63304904Pending
Related companies, and why
- ORIGIN, LLCSimilar federal contract value in Biotech · null in contracts
- Tonix Pharmaceuticals Holding Corp.Similar federal contract value in Biotech · null in contracts
- Duke Street Bio LtdSimilar federal contract value in Biotech · null in contracts
- Lattice Biologics Ltd.Similar federal contract value in Biotech · null in contracts
- EnGeneIC LtdSimilar federal contract value in Biotech · null in contracts
- ALPINE IMMUNE SCIENCES, INC.Similar federal contract value in Biotech · null in contracts
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.
Sources
Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.
How to read this page
Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.
Data freshness
SEC Form D filings through . SBIR and STTR awards through .